900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
5-Hydroxytryptamine-3-receptor antagonist adverse reaction	Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist adverse reaction (disorder)	Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose	Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose (disorder)	Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose of undetermined intent	Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist overdose of undetermined intent (disorder)	Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning	Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning (disorder)	Preferred (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent	Acceptable (foundation metadata concept)
5-Hydroxytryptamine-3-receptor antagonist poisoning of undetermined intent (disorder)	Preferred (foundation metadata concept)
5-Hydroxytryptophan measurement	Preferred (foundation metadata concept)
5-Hydroxytryptophan measurement (procedure)	Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase	Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate 3'-monooxygenase (substance)	Preferred (foundation metadata concept)
5-O-(4-coumaroyl)-D-quinate/shikimate 3'-hydroxylase	Acceptable (foundation metadata concept)
5-OH indole acetic acid (& level (& urine))	Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine))	Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) (procedure)	Preferred (foundation metadata concept)
5-OH indole acetic acid (& level (& urine)) (procedure)	Preferred (foundation metadata concept)
5-Oxoprolinase deficiency	Preferred (foundation metadata concept)
5-Oxoprolinase deficiency (disorder)	Preferred (foundation metadata concept)
5-Oxoproline	Preferred (foundation metadata concept)
5-Oxoproline (substance)	Preferred (foundation metadata concept)
5-Oxoproline + pipecolate	Preferred (foundation metadata concept)
5-Oxoproline + pipecolate (substance)	Preferred (foundation metadata concept)
5-Oxoproline measurement	Preferred (foundation metadata concept)
5-Oxoproline measurement (procedure)	Preferred (foundation metadata concept)
5-Oxoprolinuria	Acceptable (foundation metadata concept)
5-WAY LEPTOSPIROSIS VACCINE	Preferred (foundation metadata concept)
5-WAY LEPTOSPIROSIS VACCINE (product)	Preferred (foundation metadata concept)
5-alpha reductase deficiency	Acceptable (foundation metadata concept)
5-alpha reductase inhibitor	Preferred (foundation metadata concept)
5-alpha reductase inhibitor	Preferred (foundation metadata concept)
5-alpha reductase inhibitor (disposition)	Preferred (foundation metadata concept)
5-alpha reductase inhibitor-containing product	Preferred (foundation metadata concept)
5-alpha tetrahydro-11-dehydrocorticosterone	Preferred (foundation metadata concept)
5-alpha tetrahydro-11-dehydrocorticosterone (substance)	Preferred (foundation metadata concept)
5-alpha-Tetrahydrocortisol measurement	Preferred (foundation metadata concept)
5-alpha-Tetrahydrocortisol measurement (procedure)	Preferred (foundation metadata concept)
5-alpha-dihydrotestosterone	Acceptable (foundation metadata concept)
5-alpha-tetrahydrocortisol	Preferred (foundation metadata concept)
5-alpha-tetrahydrocortisol (substance)	Preferred (foundation metadata concept)
5-amino-4-imidazole carboxamide ribosiduria	Preferred (foundation metadata concept)
5-amino-4-imidazole carboxamide ribosiduria (disorder)	Preferred (foundation metadata concept)
5-amino-6-(5-phosphoribosylamino) uracil reductase	Preferred (foundation metadata concept)
5-amino-6-(5-phosphoribosylamino) uracil reductase (substance)	Preferred (foundation metadata concept)
5-aminolevulinate	Preferred (foundation metadata concept)
5-aminolevulinate (substance)	Preferred (foundation metadata concept)
5-aminolevulinate dehydratase	Acceptable (foundation metadata concept)
5-aminolevulinate synthase	Preferred (foundation metadata concept)
5-aminolevulinate synthase (substance)	Preferred (foundation metadata concept)
5-aminolevulinic acid	Preferred (foundation metadata concept)
5-aminolevulinic acid (substance)	Preferred (foundation metadata concept)
5-aminolevulinic acid hydrochloride	Acceptable (foundation metadata concept)
5-aminolevulinic acid only product	Preferred (foundation metadata concept)
5-aminolevulinic acid only product in cutaneous dose form	Preferred (foundation metadata concept)
5-aminolevulinic acid only product in oral dose form	Preferred (foundation metadata concept)
5-aminolevulinic acid-containing product	Preferred (foundation metadata concept)
5-aminolevulinic acid-containing product in cutaneous dose form	Preferred (foundation metadata concept)
5-aminolevulinic acid-containing product in oral dose form	Preferred (foundation metadata concept)
5-aminopentanamidase	Preferred (foundation metadata concept)
5-aminopentanamidase (substance)	Preferred (foundation metadata concept)
5-aminosalicylic acid	Acceptable (foundation metadata concept)
5-aminosalicylic acid	Preferred (foundation metadata concept)
5-aminosalicylic acid (substance)	Preferred (foundation metadata concept)
5-aminosalicylic acid adverse reaction	Acceptable (foundation metadata concept)
5-aminosalicylic acid adverse reaction (disorder)	Preferred (foundation metadata concept)
5-aminosalicylic acid allergy	Acceptable (foundation metadata concept)
5-aminosalicylic acid allergy	Acceptable (foundation metadata concept)
5-aminosalicylic acid overdose	Preferred (foundation metadata concept)
5-aminosalicylic acid overdose (disorder)	Preferred (foundation metadata concept)
5-aminosalicylic acid overdose of undetermined intent	Preferred (foundation metadata concept)
5-aminosalicylic acid overdose of undetermined intent (disorder)	Preferred (foundation metadata concept)
5-aminosalicylic acid poisoning	Preferred (foundation metadata concept)
5-aminosalicylic acid poisoning (disorder)	Preferred (foundation metadata concept)
5-aminosalicylic acid poisoning of undetermined intent	Preferred (foundation metadata concept)
5-aminosalicylic acid poisoning of undetermined intent (disorder)	Preferred (foundation metadata concept)
5-aminovaleramidase	Acceptable (foundation metadata concept)
5-aminovalerate aminotransferase	Preferred (foundation metadata concept)
5-aminovalerate aminotransferase (substance)	Preferred (foundation metadata concept)
5-azacytidine	Preferred (foundation metadata concept)
5-azacytidine (substance)	Preferred (foundation metadata concept)
5-beta-pregnane-3-alpha,11-beta,17,20-alpha,21-pentol	Acceptable (foundation metadata concept)
5-beta-pregnane-3-alpha,11-beta,17,20-beta,21-pentol	Acceptable (foundation metadata concept)
5-carboxymethyl-2-hydroxymuconate delta-isomerase	Preferred (foundation metadata concept)
5-carboxymethyl-2-hydroxymuconate delta-isomerase (substance)	Preferred (foundation metadata concept)
5-chloro-2-methyl-4-isothiazolin-3-one	Preferred (foundation metadata concept)
5-chloro-2-methyl-4-isothiazolin-3-one (substance)	Preferred (foundation metadata concept)
5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water)	Preferred (foundation metadata concept)
5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) (substance)	Preferred (foundation metadata concept)
5-dehydro-2-deoxygluconokinase	Preferred (foundation metadata concept)
5-dehydro-2-deoxygluconokinase (substance)	Preferred (foundation metadata concept)
5-dehydro-4-deoxyglucarate dehydratase	Preferred (foundation metadata concept)
5-dehydro-4-deoxyglucarate dehydratase (substance)	Preferred (foundation metadata concept)
5-deoxyadenosylcobalamin	Acceptable (foundation metadata concept)
5-flucytosine level	Acceptable (foundation metadata concept)
5-fluorocytosine	Acceptable (foundation metadata concept)
5-fluorouracil	Acceptable (foundation metadata concept)
5-formyltetrahydrofolate cyclo-ligase	Preferred (foundation metadata concept)
5-formyltetrahydrofolate cyclo-ligase (substance)	Preferred (foundation metadata concept)
5-guanidino-2-oxopentanoate decarboxylase	Preferred (foundation metadata concept)

Start Previous Page 122 of 13176 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)